| EC Number | Activating Compound | Comment | Organism | Structure |
|---|---|---|---|---|
| 3.4.21.108 | additional information | phosphorylation | Homo sapiens |
| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 3.4.21.108 | medicine | the identification of the role of HtrA2 in neurodegeneration will lead to an improved understanding of the pathogenesis of Parkinsons disease | Homo sapiens |
| EC Number | Protein Variants | Comment | Organism |
|---|---|---|---|
| 3.4.21.108 | A141S | polymorphism associated with Parkinsons disease | Homo sapiens |
| 3.4.21.108 | G399S | heterozygous mutation identified in Parkinsons disease patients | Homo sapiens |
| 3.4.21.108 | S142D | recombinant HtrA2 mutant, produced to determine whether HtrA2 phosphorylation affects its proteolytic activity | Homo sapiens |
| 3.4.21.108 | S400D | recombinant HtrA2 mutant, produced to determine whether HtrA2 phosphorylation affects its proteolytic activity | Homo sapiens |
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 3.4.21.108 | mitochondrion | - |
Homo sapiens | 5739 | - |
| EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|---|
| 3.4.21.108 | 35000 | - |
determined by SDS-PAGE and Western Blot analysis | Homo sapiens |
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.4.21.108 | Homo sapiens | - |
- |
- |
| EC Number | Posttranslational Modification | Comment | Organism |
|---|---|---|---|
| 3.4.21.108 | phosphoprotein | Ser142 and Ser400 | Homo sapiens |
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 3.4.21.108 | brain | - |
Homo sapiens | - |
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.4.21.108 | HtrA2 | - |
Homo sapiens |